142 related articles for article (PubMed ID: 14505586)
1. Excellent response to steroid treatment in anti-GAD cerebellar ataxia.
Lauria G; Pareyson D; Pitzolu MG; Bazzigaluppi E
Lancet Neurol; 2003 Oct; 2(10):634-5. PubMed ID: 14505586
[No Abstract] [Full Text] [Related]
2. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
[No Abstract] [Full Text] [Related]
3. Effect of steroid treatment in cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Virgilio R; Corti S; Agazzi P; Santoro D; Lanfranconi S; Candelise L; Bresolin N; Comi GP; Bersano A
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):95-6. PubMed ID: 19091718
[No Abstract] [Full Text] [Related]
4. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
[TBL] [Abstract][Full Text] [Related]
6. Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.
Simon NG; Vucic S; Joffe R; Kiernan MC
J Neurol; 2014 Jan; 261(1):238-9. PubMed ID: 24292643
[No Abstract] [Full Text] [Related]
7. Cerebellar ataxia and nystagmus with GAD antibodies in a woman from the West Indies : a video demonstration.
Ramcharan K; Reyes AJ; Abdool K; Raamkaransingh N
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31615777
[No Abstract] [Full Text] [Related]
8. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report.
Villa SM; Rufa A; Malandrini A; Cerase A; Rosini F; Arrigucci U; Federico A
Neurol Sci; 2019 Jun; 40(6):1303-1306. PubMed ID: 30635801
[No Abstract] [Full Text] [Related]
10. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
11. Brain H-MR spectroscopy in anti-GAD antibodies cerebellar ataxia.
Grimaldi G; Manto M; Jissendi Tchofo P
J Neuroradiol; 2010 Dec; 37(5):303-5. PubMed ID: 20378175
[No Abstract] [Full Text] [Related]
12. A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia.
Jones LA; Baber W; Wardle M; Robertson NP; Morris HR; Church A; Llewelyn JG; Peall KJ
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646058
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Planche V; Marques A; Ulla M; Ruivard M; Durif F
Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
[TBL] [Abstract][Full Text] [Related]
15. Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Rouco I; Hurtado P; CastaƱo L; Zarranz JJ
Neurologia; 2015 May; 30(4):247-9. PubMed ID: 24075582
[No Abstract] [Full Text] [Related]
16. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series.
Fernandes M; Munhoz RP; Carrilho PE; Arruda WO; Lorenzoni PJ; Scola RH; Werneck LC; Teive HA
Arq Neuropsiquiatr; 2012 Sep; 70(9):657-61. PubMed ID: 22990719
[TBL] [Abstract][Full Text] [Related]
17. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
19. Anti-GAD Antibody, Seizures, Cerebellar Ataxias and Vitiligo: A Diagnostic Challenge.
Flores-Cantu H; Camara-Lemarroy CR; Calderon-Hernandez HJ; Zapata-Rivera MA; Villareal-Perez JZ; Villareal-Velazquez HJ
Cerebellum; 2015 Jun; 14(3):375-7. PubMed ID: 25575726
[No Abstract] [Full Text] [Related]
20. [Autoimmune cerebellar ataxia].
Nanri K; Okuma M; Sato S; Taguchi T; Tanaka N
Nihon Rinsho; 2015 Sep; 73 Suppl 7():632-7. PubMed ID: 26480769
[No Abstract] [Full Text] [Related]
[Next] [New Search]